2020 Lautenberg Center Progress Report

Dear friends and supporters,
2020 was challenging anywhere, not sparing the Lautenberg Research Center. The corona
pandemic hit us on February and we had to adapt to a different way of living and doing science.
Nevertheless, research at the LRC has not stopped here even for an hour. On the contrary,
our student and staff realized they must continue working on their projects by all means and
additionally, volunteered in many ways to combat the pandemic. We gave a hand in building
the coronavirus testing system at the Medical School and Hadassah Medical Center, took a
major part in running the tests and many of the LRC groups proposed and carried out studies
aiming to fight the disease, from better diagnosis to developing COVID-19 therapeutics. You
may read about some of these activities in the group reports. All this was done under the harsh
work limitations of the pandemic. Students walked or cycled long hours to get to work with no
public transportation, adapted their lab schedule to two-three shifts, both day and night, and
with all that, did their best to avoid unnecessary contacts, both at home and at work to escape
the disease and home isolation due to sick people contacts. In fact, only a handful of LRC
members contracted the disease, or had to leave work for isolation.
Despite of the pandemic challenge, we had a very productive academic year in 2020. 17 new
students started working this year at the LRC and the overall student number mounted to 84.
45 LRC publications appeared during this year, in highly rated scientific journals, including
Nature, Nature Communication, eLife and PNAS. Two LRC members won the most
prestigious and rewarding ERC grants this year, turning us to the most successful department
in Israel and perhaps in Europe in winning ERC grants - three quarters of all our members
have or recently had it. Likewise, all LRC members held this year Israel Science Foundation
grants, the premier Israeli research grants. Two members of the LRC won top Israeli prizes,
The Rappaport Award for Excellence in Biomedical Research and the Art Science and Culture
EMET prize by the PM of Israel. One member was elected to the Israel Young Academy, the
most prestigious organization of young scientists in Israel. LRC is proud not only for its
academic achievements, but also for contribution to cancer therapy and two new medicines
developed at our Center, one for refractory AML and the other for immunotherapy of cancer,
have already, or will soon reach clinical studies. The AML experimental drug is already being
tested in three leading cancer centers in the US.
With the help our devoted American friends, primarily Michael Kurtz and Derek Alpert from
Concern Foundation, we have secured this year outstanding funds for the expansion of the
Lautenberg Center venue. This will allow us to recruit 3 new faculty members in a new 500
sqm wing of the Center, to be built in a floor above us. A floor program has already been
designed and the architectural and engineering plans will soon follow. We are highly grateful
to Michael and Derek for the immense effort they did in raising the needed construction funds
in nearly no time and to Moria Sapir, our devoted LRC administrating manager for mobilizing
our expansion project.
Based on the Center achievements last year, despite the pandemic difficulties, we trust that
2021, even upon on-going health challenges, will be at least as productive and rewarding as
2020.
Yinon Ben-Neriah
Head of the Concern Foundation Laboratories at Lautenberg Center for Immunology.
2